<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT2016011926099N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2016-02-07</date_registration>
      <primary_sponsor>Semnan University of Medical Sciences</primary_sponsor>
      <public_title>Effect of low level laser therapy on scar formation after cesarean section.</public_title>
      <acronym></acronym>
      <scientific_title>Relationship low level laser therapy on scar formation caused by Caesarean section.</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2016-01-06</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>62</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/21724</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Other, Purpose: Treatment.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Relationship low level laser therapy on scar formation caused by Caesarean section..</hc_freetext>
      <i_freetext>Intervention 1: Before The Intervention The Incision Site Both Groups Of Patients By 8-Megapixel Camera Iphone S6, Vertically And At A Distance Of 15 Cm Photographed. In The Experimental Group For 6 Days (24 Hours, 3, 5, 7, 9 And 11 Days After Cesarean Section) With The Mustang 2000 Is Made In Russia, To Continuously Irradiated With Gaalas Diode Laser With A Wavelength Of 830 Nm (Infrared) At A Rate Of 4 Joules Per Square Centimeter And 620 Nm Wavelength (Red) By 4 Joules Per Square Centimeter Are. 90 Degrees Angle Of The Probe On The Skin. Intervention 2: Before The Intervention The Incision Site Both Groups Of Patients By 8-Megapixel Camera Iphone S6, Vertically And At A Distance Of 15 Cm Photographed. In The Intervention Group And Control Group In The Same Conditions Laser Probe Placed On The Skin But No Laser Is Emitted. Since The Effect Of Low Level Laser On And Increase Mitochondrial ATP And Its Regenerative Effects Remain 24 To 72 Hours So We Distance Between The Laser Radiation Chose The Other Day. Resident Women In The Intervention Group Performed By Laser Irradiation And Safety Issues Are Fully Respected.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan></results_IPD_plan>
      <results_IPD_description></results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Dr Elham Saffarieh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Hospital AmirAl-Momenin Semnan</address>
        <city>Semnan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3514799442</zip>
        <telephone>+98 23 3345 1336</telephone>
        <email>eli_saffarieh@yahoo.com;drsaffarieh@semums.ac.ir</email>
        <affiliation>Semnan University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr Elham Saffarieh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Hospital AmirAl-Momenin Semnan</address>
        <city>Semnan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3514799442</zip>
        <telephone>+98 23 3345 1336</telephone>
        <email>eli_saffarieh@yahoo.com;drsaffarieh@semums.ac.ir.</email>
        <affiliation>Semnan University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Inclusion Criteria:&#13;
 Age 17 To 34; Gestational Age Between 37 To 42 Weeks; No History Of Previous Cesarean; The Absence Of Any Obstetric Complications; Lack Of Diseases That Can Delay Wound Healing; No Drugs Affecting Wound Healing And Scar; No Previous Suprapubic Scar; The Lack Of A History Of Keloid;  No Smoking Or Drugs.&#13;
&#13;
Exclusion Criteria: Duration Of Surgery&gt; 90 Min; Any Complication Of Cesarean Section; Length Of Stay&gt; 7 Days In The Hospital; Lack Of Consent For Continued Participation</inclusion_criteria>
      <agemin>17 years</agemin>
      <agemax>37 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria></exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Surgery</i_code>
      <i_code>Treatment - Surgery</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Before The Intervention The Incision Site Both Groups Of Patients By 8-Megapixel Camera Iphone S6, Vertically And At A Distance Of 15 Cm Photographed. In The Experimental Group For 6 Days (24 Hours, 3, 5, 7, 9 And 11 Days After Cesarean Section) With The Mustang 2000 Is Made In Russia, To Continuously Irradiated With Gaalas Diode Laser With A Wavelength Of 830 Nm (Infrared) At A Rate Of 4 Joules Per Square Centimeter And 620 Nm Wavelength (Red) By 4 Joules Per Square Centimeter Are. 90 Degrees Angle Of The Probe On The Skin</i_keyword>
      <i_keyword>Before The Intervention The Incision Site Both Groups Of Patients By 8-Megapixel Camera Iphone S6, Vertically And At A Distance Of 15 Cm Photographed. In The Intervention Group And Control Group In The Same Conditions Laser Probe Placed On The Skin But No Laser Is Emitted. Since The Effect Of Low Level Laser On And Increase Mitochondrial ATP And Its Regenerative Effects Remain 24 To 72 Hours So We Distance Between The Laser Radiation Chose The Other Day. Resident Women In The Intervention Group Performed By Laser Irradiation And Safety Issues Are Fully Respected.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>The Incision Site. Timepoint: In The Experimental Group For 6 Days (24 Hours, 3, 5, 7, 9 And 11 Days After Cesarean Section). Method of measurement: Mustang 2000 Machine Made In Russia, To Continuously Irradiated With Gaalas Diode Laser With A Wavelength Of 830 Nm (Infrared) At A Rate Of 4 Joules Per Square Centimeter And 620 Nm Wavelength (Red) By 4 Mj Cm Are Square. Angle Probe On The Skin Of 90 Degrees. In The Intervention Group And Control Group In The Same Conditions Laser Probe Placed On The Skin But No Laser Is Emitted. Since The Effect Of Low Level Laser On And Increase Mitochondrial Atp And Its Regenerative Effects Remain 24 To 72 Hours So We Distance Between The Laser Radiation Chose The Other Day. Resident Women In The Intervention Group Performed By Laser Irradiation And Safety Issues Are Fully Respected.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Oscar Thickness. Timepoint: 6 Months. Method of measurement: Oscar the Surgical Site With the Vancouver Scar Sale Criterion Will be Assessed and Pain, Itching and Feeling Sick to the Scar Created by Visual Analog Scale Criteria is Evaluated. Photos of AutoCAD software in 2014 (AUTOCAD 2014) entered the area of the wound in the images and the thickness of the scar created in the image measured 6 months later. Oscar Thickness at Three Points in the Middle and a Centimeter of Wound Margin is Calculated by the Software.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Semnan University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2016-01-05</approval_date>
        <contact_name>Semnan University of Medical Sciences</contact_name>
        <contact_address>Semnan University of Medical Sciences semnan  Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
